共 50 条
- [1] Treatment with cinacalcet increases plasma sclerostin concentration in hemodialysis patients with secondary hyperparathyroidism BMC NEPHROLOGY, 2016, 17 : 1 - 7
- [5] Parathyroidectomy Versus Cinacalcet for the Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients World Journal of Surgery, 2022, 46 : 813 - 819
- [7] Cinacalcet: A new treatment for secondary hyperparathyroidism in patients receiving hemodialysis PHARMACOTHERAPY, 2005, 25 (05): : 709 - 716
- [8] Treatment of secondary hyperparathyroidism with paricalcitol with or without cinacalcet in hemodialysis patients POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2017, 127 (12): : 840 - 845
- [9] Etelcalcetide controls secondary hyperparathyroidism and raises sclerostin levels in hemodialysis patients previously uncontrolled with cinacalcet NEFROLOGIA, 2023, 43 (02): : 197 - 203
- [10] Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (15): : 1516 - 1525